Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alpha-E Vita 500mg/5ml oral suspension
0906050T0BGAAAF
|
Alpha-E Vita | Tocopheryl acetate | Nutrition and Blood | 1 |
|
AlphaToc-E 200unit capsules
0906050P0DBAAAB
|
AlphaToc-E (Vitamin E) | Vitamin E | Nutrition and Blood | 1 |
|
AlphaToc-E 400unit capsules
0906050P0DBABAF
|
AlphaToc-E (Vitamin E) | Vitamin E | Nutrition and Blood | 1 |
|
Alprazolam 500microgram tablets
0401020A0AAABAB
|
Alprazolam | Alprazolam | Central Nervous System | 1 |
|
Altiven class 1 (18-21mmHg) armsleeve
21270000652
|
Altiven class 1 (18-21mmHg) armsleeve | Lymphoedema Garments | Appliances | 1 |
|
Altiven class 1 (18-21mmHg) armsleeve with grip top and mitten
21270000655
|
Altiven class 1 (18-21mmHg) armsleeve with grip top and mitten | Lymphoedema Garments | Appliances | 1 |
|
Altiven class 1 (18-21mmHg) made to measure armsleeve with mitten and elbow pocket
21270000566
|
Altiven class 1 (18-21mmHg) made to measure armsleeve with mitten and elbow pocket | Lymphoedema Garments | Appliances | 1 |
|
Altiven class 1 (18-21mmHg) thigh length open toe
21270000624
|
Altiven class 1 (18-21mmHg) thigh length open toe | Lymphoedema Garments | Appliances | 1 |
|
Altiven class 1 (18-21mmHg) thigh length open toe extra wide
21270000626
|
Altiven class 1 (18-21mmHg) thigh length open toe extra wide | Lymphoedema Garments | Appliances | 1 |
|
Altiven class 2 (23-32mmHg) made to measure thigh length open toe with waist attachment
21270000544
|
Altiven class 2 (23-32mmHg) made to measure thigh length open toe with waist attachment | Lymphoedema Garments | Appliances | 1 |
|
Altiven class 2 (23-32mmHg) thigh length closed toe
21270000635
|
Altiven class 2 (23-32mmHg) thigh length closed toe | Lymphoedema Garments | Appliances | 1 |
|
Altiven class 3 (34-46mmHg) made to measure thigh length closed toe
21270000549
|
Altiven class 3 (34-46mmHg) made to measure thigh length closed toe | Lymphoedema Garments | Appliances | 1 |
|
Aluminium acetate 8% ear drops
1201010C0AAAAAA
|
Aluminium acetate (Ear) | Aluminium acetate | Ear, Nose and Oropharynx | 1 |
|
Alvedon 60mg suppositories
0407010H0CDABCW
|
Alvedon | Paracetamol | Central Nervous System | 1 |
|
Alzhok 20mg soluble tablets
0411000G0BGABAI
|
Alzhok | Memantine hydrochloride | Central Nervous System | 1 |
|
Amgevita HCF 40mg/0.4ml inj pre-filled pens
1001030S0BCAFAD
|
Amgevita | Adalimumab | Musculoskeletal and Joint Diseases | 1 |
|
Amifampridine 20mg tablets
100201000AAAEAE
|
Generic compound preparation BNF 1002010 | Other neuromuscularar transmisson preparations | Musculoskeletal and Joint Diseases | 1 |
|
Amlodipine 1.5mg/5ml oral liquid
0206020A0AAAMAM
|
Amlodipine | Amlodipine | Cardiovascular System | 1 |
|
Amobarbital sodium 200mg capsules
0401030E0AAABAB
|
Amobarbital sodium | Amobarbital sodium | Central Nervous System | 1 |
|
Amoxicillin 1g powder for solution for injection vials
0501013C0AAAEAE
|
Amoxicillin sodium | Amoxicillin sodium | Infections | 1 |
|
Amoxil 125mg/1.25ml paediatric oral suspension
0501013B0BCAGAI
|
Amoxil (Systemic) | Amoxicillin | Infections | 1 |
|
Ampicillin 500mg powder for solution for injection vials
0501013E0AAADAD
|
Ampicillin | Ampicillin | Infections | 1 |
|
Ancora 375 Cu intrauterine contraceptive device
21040000258
|
Ancora 375 Cu intrauterine contraceptive device | Contraceptive Devices | Appliances | 1 |
|
Angilol 10mg tablets
0204000R0BZACAH
|
Angilol (Genesis Pharmaceuticals Ltd) | Propranolol hydrochloride | Cardiovascular System | 1 |
|
Anugesic-HC suppositories
0107020J0BBABAI
|
Anugesic HC | Hydrocortisone | Gastro-Intestinal System | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.